EGFR and non-small cell lung carcinoma: Compared with other pooled studies, the study by Fujita et al. [15] was the first and only study which indicated a positive correlation between pretreatment T790M patients and prognosis on PFS in advanced NSCLC patients treated with EGFR TKIs.